Cyrus Harmon

Cyrus Harmon

Gründer bei OLEMA PHARMACEUTICALS, INC.

Vermögen: 9 Mio $ am 30.04.2024

53 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Cyrus Harmon

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 23
Subsidiary Medical Specialties 18

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Cyrus Harmon

UnternehmenSektorVerknüpfte PersonenHauptposition
AMGEN INC. Pharmaceuticals: Major

J. Garland

John Moriarty

Sales & Marketing

Director/Board Member

E I DU PONT DE NEMOURS AND CO Chemicals: Agricultural

Pat Brooks

Corporate Officer/Principal

Biotechnology

Ian Clark

J. Garland

Robert S. Michitarian

Pamela Klein

Sean Bohen

Sandra Horning

Kinney Horn

Chief Executive Officer

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

HP INC. Computer Processing Hardware

Gregory Schiffman

Robert H. Ellis

Corporate Officer/Principal

Corporate Officer/Principal

IBM Packaged Software

Andy Rappaport

Gregory Schiffman

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Pat Brooks

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

John Moriarty

General Counsel

EXELIXIS, INC. Pharmaceuticals: Major

Francis McCormick

J. Garland

Director/Board Member

Corporate Officer/Principal

STANDARD BIOTOOLS INC. Medical Specialties

Kenneth J. Nussbacher

John Stark

Director/Board Member

Corporate Officer/Principal

Wholesale Distributors

Pat Brooks

Corporate Officer/Principal

CAREDX, INC Medical Specialties

Dirk Lammerts

Grace Colón

Corporate Officer/Principal

Director/Board Member

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Medical Specialties

Pat Brooks

John Stark

Sales & Marketing

Sales & Marketing

PORTOLA PHARMACEUTICALS, INC. Pharmaceuticals: Major

J. Garland

John Moriarty

Chief Executive Officer

General Counsel

Medical Specialties

Grace Colón

Chairman

PRECIGEN, INC. Biotechnology

Grace Colón

Corporate Officer/Principal

Miscellaneous Commercial Services

Ian Clark

Grace Colón

Director/Board Member

Director/Board Member

Semiconductors

Jamie Kole

Alan Williams

Director of Finance/CFO

Corporate Officer/Principal

PELOTON THERAPEUTICS, INC. Pharmaceuticals: Major

Francis McCormick

Naseem Zojwalla

Director/Board Member

Chief Tech/Sci/R&D Officer

Biotechnology

Grace Colón

Director/Board Member

TURG POIN Pharmaceuticals: Major

Yi Larson

Naseem Zojwalla

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

University of Virginia College/University

Robert S. Michitarian

John Moriarty

Graduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Dirk Lammerts

Grace Colón

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

Robert S. Michitarian

Naseem Zojwalla

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Grace Colón

Undergraduate Degree

Investment Managers

Marina Bozilenko

Corporate Officer/Principal

Miscellaneous Commercial Services

Barbara A. Caulfield

Robert S. Michitarian

Corporate Officer/Principal

Corporate Officer/Principal

The University of California, San Francisco College/University

Sean Bohen

Gorjan Hrustanovic

Peter Kushner

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

FORTY SEVEN, INC. Pharmaceuticals: Major

Ian Clark

Florence Zhu

Director/Board Member

Comptroller/Controller/Auditor

Stanford University School of Medicine College/University

Sandra Horning

Graham Walmsley

Corporate Officer/Principal

Doctorate Degree

KITE PHARMA INC Biotechnology

Ian Clark

Cynthia Butitta

Director/Board Member

Director of Finance/CFO

University of California, Berkeley College/University

Alan Williams

Graham Walmsley

Doctorate Degree

Undergraduate Degree

University of Iowa College/University

Pat Brooks

Sandra Horning

Graduate Degree

Doctorate Degree

GYROSCOPE THERAPEUTICS HOLDINGS PLC Biotechnology

Ian Clark

Sean Bohen

Director/Board Member

Director/Board Member

ALX ONCOLOGY HOLDINGS INC. Biotechnology

J. Garland

Graham Walmsley

Director/Board Member

Director/Board Member

California Polytechnic State University (San Luis Obispo) College/University

J. Garland

Kristin Lanzi

Undergraduate Degree

Undergraduate Degree

IOVANCE BIOTHERAPEUTICS, INC. Biotechnology

Gregory Schiffman

Kristin Lanzi

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Massachusetts Institute of Technology College/University

Grace Colón

Yi Larson

Director/Board Member

Graduate Degree

University of Wisconsin College/University

Cynthia Butitta

Sean Bohen

Masters Business Admin

Undergraduate Degree

SYNACT PHARMA AB Pharmaceuticals: Major

Marina Bozilenko

Director/Board Member

Financial Conglomerates

Marina Bozilenko

Director/Board Member

Biotechnology

Grace Colón

Chief Executive Officer

University of Massachusetts College/University

Grace Colón

Doctorate Degree

Pharmaceuticals: Major

Pat Brooks

Sales & Marketing

Statistik

International

Vereinigte Staaten 45
Irland 2
Belgien 2
Vereinigtes Königreich 2
Schweden 2

Sektoral

Health Technology 27
Consumer Services 11
Commercial Services 5
Finance 4
Electronic Technology 3

Operativ

Director/Board Member 151
Corporate Officer/Principal 109
Independent Dir/Board Member 54
Undergraduate Degree 37
Founder 23
  1. Börse
  2. Insiders
  3. Cyrus Harmon
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT